benzyl 2-amino-5-azaspiro[2.4]heptane-5-carboxylate
![]() |
- $1429 - $2574
- Product name: benzyl 2-amino-5-azaspiro[2.4]heptane-5-carboxylate
- CAS: 1419101-17-9
- MF: C14H18N2O2
- MW: 246.3
- EINECS:
- MDL Number:MFCD23106447
- Synonyms:benzyl 2-amino-5-azaspiro[2.4]heptane-5-carboxylate;1-Amino-5-Cbz-5-aza-spiro[2.4]heptane;benzyl 1-amino-5-azaspiro[2.4]heptane-5-carboxylate;5-Azaspiro[2.4]heptane-5-carboxylic acid, 1-amino-, phenylmethyl ester
4 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- Matrix Scientific
- Synthonix
Package
- 1g
- ManufacturerChemenu
- Product numberCM209090
- Product description1-Amino-5-Cbz-5-aza-spiro[2.4]heptane 95%
- Packaging1g
- Price$1429
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11261041
- Product description1-Amino-5-Cbz-5-aza-spiro[2.4]heptane 95+%
- Packaging1g
- Price$1516
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number123335
- Product description1-Amino-5-Cbz-5-aza-spiro[2.4]heptane 95+%
- Packaging1g
- Price$2574
- Updated2021-12-16
- Buy
- ManufacturerSynthonix
- Product numberA13197
- Product description1-Amino-5-Cbz-5-aza-spiro[2.4]heptane 95+%
- Packaging1g
- Price$1460
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM209090 | 1-Amino-5-Cbz-5-aza-spiro[2.4]heptane 95% | 1g | $1429 | 2021-12-16 | Buy |
Crysdot | CD11261041 | 1-Amino-5-Cbz-5-aza-spiro[2.4]heptane 95+% | 1g | $1516 | 2021-12-16 | Buy |
Matrix Scientific | 123335 | 1-Amino-5-Cbz-5-aza-spiro[2.4]heptane 95+% | 1g | $2574 | 2021-12-16 | Buy |
Synthonix | A13197 | 1-Amino-5-Cbz-5-aza-spiro[2.4]heptane 95+% | 1g | $1460 | 2021-12-16 | Buy |
Properties
Boiling point :391.0±35.0 °C(Predicted)
Density :1.24±0.1 g/cm3(Predicted)
pka :8.87±0.20(Predicted)
Density :1.24±0.1 g/cm3(Predicted)
pka :8.87±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|